PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026 Overview

PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026 Cost of Revenue

Cost of Revenue analysis for PBAXW.

Quarterly Cost of Revenue

N/A

Annual Cost of Revenue (TTM)

N/A

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin